We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
-
- Other
Akebia Therapeutics works to develop unique therapeutics that have the potential to set new standards of care for people living with kidney disease. Akebia is a fully integrated biopharmaceutical comp ... -
.jpg)
- Orphan/Rare Diseases
Artasome Therapeutics is a pre-clinical stage company focused on the treatment of innate driven, inflammatory-fibrotic (IDIF) rare diseases associated with significant morbidity and mortality. NLRP3 a ... -
- Ophthalmology
Ashvattha Therapeutics is advancing a new class of clinical-stage nanomedicine therapeutics that traverse tissue barriers to selectively target activated cells only in regions of inflammation. Our tar ... -
- Orphan/Rare Diseases
BOOST Pharma is a clinical-stage biopharmaceutical company focused on the development of novel cell therapy treatments. The company is currently developing a first-in-class therapy to treat Osteogenes ... -
- Platform for Therapeutics
Bound Therapeutics is a pioneering biotechnology company dedicated to the development of RNA-based therapies targeting rare and refractory diseases, with a primary focus on oncology. Our proprietary p ... -
- Multiple Therapeutics
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in ... -
- Immunology
Canopy is an emerging biotech redefining autoimmune therapeutics through its groundbreaking Antigen-Drug Conjugate (AgDC) platform. Backed by leading US-based VCs, the company is led by Dr. Kfir Oved, ... -
- Gene/Cell Therapy
Carina Biotech is clinical stage, immuno-oncology company developing CAR-T and other adoptive cell therapies for the treatment of solid cancers. Its lead candidate, CNA3103, targets LGR5 a cancer stem ... -
- Oncology
Cellinfinity is a Yale University spinoff, seed funded company (raised $16 mil, including $3mil from NIH) that has developed novel: 1) in vivo CAR-T vectors and 2) multi-gene edited CAR-Ts against sol ... -
- Multiple Therapeutics
Cellphire Therapeutics is a clinical stage Biotech believes no-one should die from controllable hemorrhage. We are revolutionizing bleeding treatment with platelet derived therapeutics. With a late st ... -
- Oncology
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products. In August 2024, the FDA approved ... -
- Reproductive/Sexual Health
Daré Bioscience is a biopharmaceutical company committed to advancing innovative products for women’s health. The company’s mission is to identify, develop and bring to market a diverse portfolio of d ... -
- Gastrointestinal
Our mission is to restore voluntary bowel and bladder function to patients with neurological conditions such as spinal cord injury or have complications from other diseases such as diabetes, Parkinson ... -
- Other
Dimer Pharmaceuticals is transforming cancer and neurodegenerative disease treatment with its innovative “Oncodegenic Approach.” This strategy leverages an epidemiological connection between these con ... -
.png)
- Inflammation
Enveda is a biotechnology company aiming to understand and utilize the chemistry that forms the foundation of life. Using their AI-powered tools to identify and characterize the diverse molecules that ... -
- Ophthalmology
Epion Therapeutics is developing a minimally -invasive treatment for ectatic corneal disease that can bring early intervention to millions of patients globally. Our EpiSmart approach is a transformat ... -
- Gastrointestinal
Eupraxia Pharmaceuticals is a biotechnology company focused on precision delivery of drugs into disease tissues using its proprietary Diffusphere technology. With its lead program in Eosinophilic Esop ... -
- Regenerative Medicine
EVast Bio is a US-based clinical-stage biotech spinoff and Delaware C Corp pioneering the development of small Extracellular Vesicle (sEV) therapeutics. Our proprietary platform leverages these natura ... -
- Orphan/Rare Diseases
EveryONE Medicines is committed to developing individualized anti-sense oligonucleotides targeting unique genetic variants causing severe neurodegenerative disease, even if unique to just one person. -
- Immunology
GeoVax is developing novel vaccines for infectious diseases and therapies for solid tumor cancers. Its lead clinical program is a next-generation COVID-19 vaccine for which GeoVax was awarded a BARDA- ... -
- Oncology
Greenwich LifeSciences (Nasdaq: GLSI) is a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating the safety and efficacy of GP2, an immunot ... -
- Inflammation
Recognizing the link between inflammation and numerous chronic diseases, including Alzheimer’s, cardiovascular disease, cancer, and various disorders of the skin, intestines, and liver, Halia expanded ... -
- Oncology
ImmuneOnco is a HK-listed (HK.1541), clinical stage biotech company focused on discovering and developing immunotherapies to treat cancer and other diseases. The most advanced program is phase III tim ... -
.png)
- CNS/Neurological
KeifeRx (www.keiferx.com) is on a mission to improve the lives of dementia patients and their families by slowing down the onset of dementia by years compared to current treatment options. -
- Metabolic Diseases
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through the Genome5000™ program, Lexicon’s unique genomics target discovery platform, Lexi ... -
- Oncology
Lisata Therapeutics is a clinical-stage pharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies for the treatment of advanced solid tumors and othe ... -
- CNS/Neurological
Magdalena Biosciences, Inc. has a paradigm shifting drug development approach, 12-24 months from plant collection to clinical POC study initiation possible; de-risk early with higher probability for f ... -
- Oncology
Medicovestor, Inc pioneers novel Antibody Drug Conjugate (ADC) platforms to bridge the therapeutic gaps of existing ADCs. It leverages the complementary expertise and extensive experience of each memb ... -
- Oncology
MetasTx is working to block metastases of cancer cells from solid tumors including prostate, breast and skin by early detection and blockade of mesenchymal-to-epithelial transition (EMT). Creating nov ... -
- CNS/Neurological
Newron (SIX: NWRN, XETRA: NP5) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The Company is head ... -
- CNS/Neurological
NurrOn Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company (Boston, USA) dedicated to developing novel, targeted therapeutics for the treatment of Parkinson's disease (PD) and other Nur ... -
- Inflammation
Armed with a novel approach for resolving inflammation and expertise ranging from drug discovery through FDA approval, we merge future-focused intention with data-driven innovation. We have earned our ... -
- CNS/Neurological
PathMaker Neurosystems is a clinical-stage company developing a breakthrough, non-invasive approach to the treatment of ALS (amyotrophic lateral sclerosis), an incurable neurodegenerative disease that ... -
- CNS/Neurological
ProMIS Neurosciences Inc. is a clinical stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative disea ... -
- Orphan/Rare Diseases
Protalix is a biopharmaceutical company focused on the development, production, and commercialization of innovative medicines for patients living with rare diseases. We are advancing promising candida ... -
- Oncology
Radiance is developing next generation Antibody Drug Conjugates and Bispecific ADCs. The Company's lead asset , RB164, an ROR1 ADC, is clinic ready. RB201, is a HER2/TROP2 BsADC, with next generation ... -
- Oncology
Clinical stage Radiopharmaceutical company with therapeutic and imaging molecules. Currently in Phase 1 and Phase 2. -
- Oncology
Rakuten Medical, Inc. is a global biotechnology company founded in 2010, dedicated to developing and commercializing precision cell-targeting therapies through our proprietary Alluminox™ platform. All ... -
- Platform for Therapeutics
Seek Labs is developing a programmable rapid response therapeutic platform for target ablation that leverages CRISPR technology. The platform seeks and destroys infectious pathogens and disease-drivin ... -
- Oncology
SirnaMed Therapeutics is a pioneering biotechnology company driven by the vision of inventing a future without cancer. We are developing a novel class of RNA interference (RNAi) therapeutics that leve ... -
Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our Specialized BioTherapeutics busi ... -
- CNS/Neurological
Sound Pharma is developing the first drugs to treat hearing loss and tinnitus affecting 50M Americans (the largest CNS/PNS disease). It has advanced its novel small molecule (SPI-1005) through 13 stud ... -
- Multiple Therapeutics
supernova bio, a bio-venture specializing in R&D, has developed innovative theragnostic therapies by creating gas-generating polymer nanoparticles that overcome the limitations of conventional chemoth ... -
- Pain Management
Sustained Therapeutics is a clinical stage company developing non-opioid locally injected therapeutics for the treatment of pain. Our novel sustained-release drug delivery platform has the potential t ... -
- CNS/Neurological
Tonix is a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates. Tonix’s lead program, TNX-102 SL, is a U.S. FDA Fast-Track designated product can ... -
- Oncology
TrAMPoline Pharma was founded with a vision to support the next generation of cellular immunotherapies to treat solid tumors. We are developing vectors encoding proprietary co-receptor and signaling p ... -
- Reproductive/Sexual Health
Vaneltix Pharma, Inc. is a private clinical stage biotech focused on developing pharmaceutical products for the treatment of urologic conditions with high unmet need, with a focus on bladder condition ... -
- CNS/Neurological
Vistagen (Nasdaq: VTGN) a late clinical-stage company leveraging its pioneering neuroscience and deep understanding of nose-to-brain neurocircuitry to develop and commercialize a broad and diverse pip ... -
- Infectious Diseases
Ziphius is a biotechnology company developing best-in-class vaccines and therapeutics based on its proprietary saRNA and carrier technology (LNP) platform. This platform enables higher and prolonged p ...
.jpg)
)
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}